FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2766983668> ?p ?o ?g. }

• W2766983668 endingPage "1426" @default.
• W2766983668 startingPage "1418" @default.
• W2766983668 abstract "What is the cost-effectiveness of lifestyle intervention preceding infertility treatment in obese infertile women?Lifestyle intervention preceding infertility treatment as compared to prompt infertility treatment in obese infertile women is not a cost-effective strategy in terms of healthy live birth rate within 24 months after randomization, but is more likely to be cost-effective using a longer follow-up period and live birth rate as endpoint.In infertile couples, obesity decreases conception chances. We previously showed that lifestyle intervention prior to infertility treatment in obese infertile women did not increase the healthy singleton vaginal live birth rate at term, but increased natural conceptions, especially in anovulatory women. Cost-effectiveness analyses could provide relevant additional information to guide decisions regarding offering a lifestyle intervention to obese infertile women.The cost-effectiveness of lifestyle intervention preceding infertility treatment compared to prompt infertility treatment was evaluated based on data of a previous RCT, the LIFEstyle study. The primary outcome for effectiveness was the vaginal birth of a healthy singleton at term within 24 months after randomization (the healthy live birth rate). The economic evaluation was performed from a hospital perspective and included direct medical costs of the lifestyle intervention, infertility treatments, medication and pregnancy in the intervention and control group. In addition, we performed exploratory cost-effectiveness analyses of scenarios with additional effectiveness outcomes (overall live birth within 24 months and overall live birth conceived within 24 months) and of subgroups, i.e. of ovulatory and anovulatory women, women <36 years and ≥36 years of age and of completers of the lifestyle intervention. Bootstrap analyses were performed to assess the uncertainty surrounding cost-effectiveness.Infertile women with a BMI of ≥29 kg/m2 (no upper limit) were allocated to a 6-month lifestyle intervention programme preceding infertility treatment (intervention group, n = 290) or to prompt infertility treatment (control group, n = 287). After excluding women who withdrew informed consent or who were lost to follow-up we included 280 women in the intervention group and 284 women in the control group in the analysis.Total mean costs per woman in the intervention group within 24 months after randomization were €4324 (SD €4276) versus €5603 (SD €4632) in the control group (cost difference of -€1278, P < 0.05). Healthy live birth rates were 27 and 35% in the intervention group and the control group, respectively (effect difference of -8.1%, P < 0.05), resulting in an incremental cost-effectiveness ratio of €15 845 per additional percentage increase of the healthy live birth rate. Mean costs per healthy live birth event were €15 932 in the intervention group and €15 912 in the control group. Exploratory scenario analyses showed that after changing the effectiveness outcome to all live births conceived within 24 months, irrespective of delivery within or after 24 months, cost-effectiveness of the lifestyle intervention improved. Using this effectiveness outcome, the probability that lifestyle intervention preceding infertility treatment was cost-effective in anovulatory women was 40%, in completers of the lifestyle intervention 39%, and in women ≥36 years 29%.In contrast to the study protocol, we were not able to perform the analysis from a societal perspective. Besides the primary outcome of the LIFEstyle study, we performed exploratory analyses using outcomes observed at longer follow-up times and we evaluated subgroups of women; the trial was not powered on these additional outcomes or subgroup analyses.Cost-effectiveness of a lifestyle intervention is more likely for longer follow-up times, and with live births conceived within 24 months as the effectiveness outcome. This effect was most profound in anovulatory women, in completers of the lifestyle intervention and in women ≥36 years old. This result indicates that the follow-up period of lifestyle interventions in obese infertile women is important. The scenario analyses performed in this study suggest that offering and reimbursing lifestyle intervention programmes in certain patient categories may be cost-effective and it provides directions for future research in this field.The study was supported by a grant from ZonMw, the Dutch Organization for Health Research and Development (50-50110-96-518). The department of obstetrics and gynaecology of the UMCG received an unrestricted educational grant from Ferring pharmaceuticals BV, The Netherlands. B.W.J.M. is a consultant for ObsEva, Geneva.The LIFEstyle RCT was registered at the Dutch trial registry (NTR 1530). http://www.trialregister.nl/trialreg/admin/rctview.asp?TC = 1530." @default.
• W2766983668 created "2017-11-10" @default.
• W2766983668 creator A5006070460 @default.
• W2766983668 creator A5014311522 @default.
• W2766983668 creator A5014590526 @default.
• W2766983668 creator A5017654932 @default.
• W2766983668 creator A5029708899 @default.
• W2766983668 creator A5039792476 @default.
• W2766983668 creator A5056441991 @default.
• W2766983668 creator A5066811784 @default.
• W2766983668 creator A5068425141 @default.
• W2766983668 creator A5077107849 @default.
• W2766983668 creator A5077604971 @default.
• W2766983668 creator A5081977191 @default.
• W2766983668 creator A5082503529 @default.
• W2766983668 creator A5090795384 @default.
• W2766983668 creator A5091296628 @default.
• W2766983668 date "2017-05-09" @default.
• W2766983668 modified "2023-09-25" @default.
• W2766983668 title "Cost-effectiveness analysis of lifestyle intervention in obese infertile women" @default.
• W2766983668 cites W1964863515 @default.
• W2766983668 cites W1987156738 @default.
• W2766983668 cites W2041566613 @default.
• W2766983668 cites W2053728092 @default.
• W2766983668 cites W2094044631 @default.
• W2766983668 cites W2095829298 @default.
• W2766983668 cites W2098199441 @default.
• W2766983668 cites W2103446289 @default.
• W2766983668 cites W2113318243 @default.
• W2766983668 cites W2118485114 @default.
• W2766983668 cites W2130500449 @default.
• W2766983668 cites W2134397364 @default.
• W2766983668 cites W2140818012 @default.
• W2766983668 cites W2141529825 @default.
• W2766983668 cites W2146252533 @default.
• W2766983668 cites W2146787987 @default.
• W2766983668 cites W2156170866 @default.
• W2766983668 cites W2166000404 @default.
• W2766983668 cites W2167179017 @default.
• W2766983668 cites W2214780485 @default.
• W2766983668 cites W2258937362 @default.
• W2766983668 cites W2369321124 @default.
• W2766983668 cites W2404662288 @default.
• W2766983668 cites W2532631027 @default.
• W2766983668 doi "https://doi.org/10.1093/humrep/dex092" @default.
• W2766983668 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28486704" @default.
• W2766983668 hasPublicationYear "2017" @default.
• W2766983668 type Work @default.
• W2766983668 sameAs 2766983668 @default.
• W2766983668 citedByCount "17" @default.
• W2766983668 countsByYear W27669836682018 @default.
• W2766983668 countsByYear W27669836682019 @default.
• W2766983668 countsByYear W27669836682020 @default.
• W2766983668 countsByYear W27669836682021 @default.
• W2766983668 countsByYear W27669836682022 @default.
• W2766983668 countsByYear W27669836682023 @default.
• W2766983668 crossrefType "journal-article" @default.
• W2766983668 hasAuthorship W2766983668A5006070460 @default.
• W2766983668 hasAuthorship W2766983668A5014311522 @default.
• W2766983668 hasAuthorship W2766983668A5014590526 @default.
• W2766983668 hasAuthorship W2766983668A5017654932 @default.
• W2766983668 hasAuthorship W2766983668A5029708899 @default.
• W2766983668 hasAuthorship W2766983668A5039792476 @default.
• W2766983668 hasAuthorship W2766983668A5056441991 @default.
• W2766983668 hasAuthorship W2766983668A5066811784 @default.
• W2766983668 hasAuthorship W2766983668A5068425141 @default.
• W2766983668 hasAuthorship W2766983668A5077107849 @default.
• W2766983668 hasAuthorship W2766983668A5077604971 @default.
• W2766983668 hasAuthorship W2766983668A5081977191 @default.
• W2766983668 hasAuthorship W2766983668A5082503529 @default.
• W2766983668 hasAuthorship W2766983668A5090795384 @default.
• W2766983668 hasAuthorship W2766983668A5091296628 @default.
• W2766983668 hasBestOaLocation W27669836681 @default.
• W2766983668 hasConcept C112930515 @default.
• W2766983668 hasConcept C118552586 @default.
• W2766983668 hasConcept C131872663 @default.
• W2766983668 hasConcept C141071460 @default.
• W2766983668 hasConcept C168563851 @default.
• W2766983668 hasConcept C2777688143 @default.
• W2766983668 hasConcept C2778279030 @default.
• W2766983668 hasConcept C2779234561 @default.
• W2766983668 hasConcept C2780665704 @default.
• W2766983668 hasConcept C29456083 @default.
• W2766983668 hasConcept C3019080777 @default.
• W2766983668 hasConcept C54355233 @default.
• W2766983668 hasConcept C71924100 @default.
• W2766983668 hasConcept C86803240 @default.
• W2766983668 hasConceptScore W2766983668C112930515 @default.
• W2766983668 hasConceptScore W2766983668C118552586 @default.
• W2766983668 hasConceptScore W2766983668C131872663 @default.
• W2766983668 hasConceptScore W2766983668C141071460 @default.
• W2766983668 hasConceptScore W2766983668C168563851 @default.
• W2766983668 hasConceptScore W2766983668C2777688143 @default.
• W2766983668 hasConceptScore W2766983668C2778279030 @default.
• W2766983668 hasConceptScore W2766983668C2779234561 @default.
• W2766983668 hasConceptScore W2766983668C2780665704 @default.
• W2766983668 hasConceptScore W2766983668C29456083 @default.
• W2766983668 hasConceptScore W2766983668C3019080777 @default.

• next